The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism
- PMID: 15349859
- DOI: 10.1002/ana.20206
The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism
Abstract
Mutations in the PINK1 gene (PARK6), a putative serine-threonine kinase, cause autosomal recessive Parkinson's disease. PINK1 functions as a protein kinase and confers protective effects in the mitochondria, where it is primarily located. We assessed in a population of European ancestry whether common genetic variation in this novel gene influences nonmendelian forms of Parkinson's disease. We defined the linkage disequilibrium structure of PINK1 and used this to identify a set of tagging single nucleotide polymorphisms that we estimate will efficiently represent all of the common DNA variation in the entire gene. Genotyping these tags in a set of 576 Parkinson's disease patients and 514 controls did not demonstrate a case-control partition for allele or for haplotype and thus provides evidence against the existence of a common functional variants in PINK1 that has a strong influence on PD risk.
Similar articles
-
Comprehensive assessment of PINK1 variants in Parkinson's disease.Neurobiol Aging. 2020 Jul;91:168.e1-168.e5. doi: 10.1016/j.neurobiolaging.2020.03.003. Epub 2020 Mar 10. Neurobiol Aging. 2020. PMID: 32249012 Free PMC article.
-
Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.BMC Neurol. 2008 Dec 16;8:47. doi: 10.1186/1471-2377-8-47. BMC Neurol. 2008. PMID: 19087301 Free PMC article.
-
Assessment of PINK1 (PARK6) polymorphisms in Finnish PD.Neurobiol Aging. 2006 Jun;27(6):906-7. doi: 10.1016/j.neurobiolaging.2005.03.028. Epub 2005 Jul 19. Neurobiol Aging. 2006. PMID: 16046032
-
[Molecular genetics of PINK1].Brain Nerve. 2007 Aug;59(8):831-8. Brain Nerve. 2007. PMID: 17713119 Review. Japanese.
-
Genetic mutations and functions of PINK1.Trends Pharmacol Sci. 2011 Oct;32(10):573-80. doi: 10.1016/j.tips.2011.06.001. Epub 2011 Jul 23. Trends Pharmacol Sci. 2011. PMID: 21784538 Review.
Cited by
-
Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.J Neural Transm (Vienna). 2017 Jan;124(1):57-78. doi: 10.1007/s00702-016-1633-3. Epub 2016 Oct 28. J Neural Transm (Vienna). 2017. PMID: 27796511
-
Exclusion of PINK1 as candidate gene for the late-onset form of Parkinson's disease in two European populations.J Negat Results Biomed. 2005 Dec 14;4:10. doi: 10.1186/1477-5751-4-10. J Negat Results Biomed. 2005. PMID: 16354302 Free PMC article.
-
PINK1 mutation in Taiwanese early-onset parkinsonism : clinical, genetic, and dopamine transporter studies.J Neurol. 2007 Oct;254(10):1347-55. doi: 10.1007/s00415-007-0534-7. Epub 2007 Oct 15. J Neurol. 2007. PMID: 17960343
-
Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance.J Neurochem. 2016 Oct;139 Suppl 1(Suppl 1):59-74. doi: 10.1111/jnc.13593. Epub 2016 Apr 18. J Neurochem. 2016. PMID: 27090875 Free PMC article. Review.
-
Gene-environment interactions: key to unraveling the mystery of Parkinson's disease.Prog Neurobiol. 2011 Jun;94(1):1-19. doi: 10.1016/j.pneurobio.2011.03.005. Epub 2011 Mar 23. Prog Neurobiol. 2011. PMID: 21439347 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical